Parity and gastric cancer risk: A systematic review and dose-response meta-Analysis of prospective cohort studies

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Jing ^a   Gong, Ting Ting ^a   Wu, Qi Jun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; META ANALYSIS; ODDS RATIO; PARITY; PREGNANCY; PROSPECTIVE STUDY; RISK; RISK FACTOR; STOMACH NEOPLASMS;

FEMALE; HUMANS; ODDS RATIO; PARITY; PREGNANCY; PROSPECTIVE STUDIES; RISK; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84952931225     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18766     Document Type: Review

References (57)

1. Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin 65, 87-108 (2015).
2. Ferlay, J. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. (Date of access: 17/November/2015).
3. Karimi, P. et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 23, 700-13 (2014).
4. Chandanos, E. & Lagergren, J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer 44, 2397-403 (2008).
5. Sipponen, P. & Correa, P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5, 213-9 (2002).
6. Furukawa, H., Iwanaga, T., Koyama, H. & Taniguchi, H. Effect of sex hormones on carcinogenesis in the stomachs of rats. Cancer Res 42, 5181-2 (1982).
7. Furukawa, H., Iwanaga, T., Koyama, H. & Taniguchi, H. Effect of sex hormones on the experimental induction of cancer in rat stomach -A preliminary study. Digestion 23, 151-5 (1982).
8. Bahmanyar, S. et al. Parity and risk of stomach cancer by sub-site: a national Swedish study. Br J Cancer 98, 1295-300 (2008).
9. Guan, H. B., Wu, Q. J. & Gong, T. T. Parity and kidney cancer risk: evidence from epidemiologic studies. Cancer Epidemiol Biomarkers Prev 22, 2345-53 (2013).
10. Guan, H. B. et al. Parity and risk of colorectal cancer: a dose-response meta-Analysis of prospective studies. PLoS One 8, e75279 (2013).
11. Guan, H. B. et al. Parity and pancreatic cancer risk: a dose-response meta-Analysis of epidemiologic studies. PLoS One 9, e92738 (2014).
12. Campbell-Thompson, M. L. Estrogen receptor alpha and beta expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats. Biochem Biophys Res Commun 240, 478-83 (1997).
13. Katoh, M. Trefoil factors and human gastric cancer (review). Int J Mol Med 12, 3-9 (2003).
14. Oshima, C. T. et al. Estrogen and progesterone receptors in gastric and colorectal cancer. Hepatogastroenterology 46, 3155-8 (1999).
15. Green, J. et al. Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort. Br J Cancer 106, 210-6 (2012).
16. Chang, C. C., Chen, C. C., Chiu, H. F. & Yang, C. Y. Higher parity associated with higher risk of death from gastric cancer. World J Gastroenterol 17, 784-8 (2011).
17. Duell, E. J. et al. Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol 172, 1384-93 (2010).
18. Freedman, N. D. et al. The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIHAARP cohort. Cancer 116, 1572-81 (2010).
19. Persson, C. et al. Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 17, 345-53 (2008).
20. Freedman, N. D. et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut 56, 1671-7 (2007).
21. Koski-Rahikkala, H., Pouta, A., Pietilainen, K. & Hartikainen, A. L. Does parity affect mortality among parous women? J Epidemiol Community Health 60, 968-73 (2006).
22. Kaneko, S. et al. Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control 14, 53-9 (2003).
23. Heuch, I. & Kvale, G. Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control 11, 869-74 (2000).
24. Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-Type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64, 31-49 (1965).
25. Wu, Q. J. et al. Cruciferous vegetable consumption and gastric cancer risk: a meta-Analysis of epidemiological studies. Cancer Sci 104, 1067-73 (2013).
26. Sipponen, P. & Correa, P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5, 213-9 (2002).
27. Camargo, M. C. et al. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-Analysis. Cancer Epidemiol Biomarkers Prev 21, 20-38 (2012).
28. Karat, D. et al. Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study. Br J Cancer 80, 1271-4 (1999).
29. Takano, N. et al. Expression of estrogen receptor-Alpha and -beta mRNAs in human gastric cancer. Cancer Lett 176, 129-35 (2002).
30. De Bosscher, K., Vanden, B. W. & Haegeman, G. Cross-Talk between nuclear receptors and nuclear factor kappaB. Oncogene 25, 6868-86 (2006).
31. Kalaitzidis, D. & Gilmore, T. D. Transcription factor cross-Talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab 16, 46-52 (2005).
32. Pfeilschifter, J., Koditz, R., Pfohl, M. & Schatz, H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23, 90-119 (2002).
33. La Vecchia, C., Negri, E., Franceschi, S. & Parazzini, F. Long-Term impact of reproductive factors on cancer risk. Int J Cancer 53, 215-9 (1993).
34. Watson, S. A., Grabowska, A. M., El-Zaatari, M. & Takhar, A. Gastrin -Active participant or bystander in gastric carcinogenesis? Nat Rev Cancer 6, 936-46 (2006).
35. Lanciers, S., Despinasse, B., Mehta, D. I. & Blecker, U. Increased susceptibility to Helicobacter pylori infection in pregnancy. Infect Dis Obstet Gynecol 7, 195-8 (1999).
36. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61, 1-241 (1994).
37. Wu, Q. J. et al. Parity and endometrial cancer risk: a meta-Analysis of epidemiological studies. Sci Rep 5, 14243 (2015).
38. Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. BMJ 339, b2535 (2009).
39. Wu, Q. J. et al. Cruciferous vegetables intake and the risk of colorectal cancer: a meta-Analysis of observational studies. Ann Oncol 24, 1079-87 (2013).
40. Luan, N. N. et al. Nonlinear reduction in risk for colorectal cancer by oral contraceptive use: a meta-Analysis of epidemiological studies. Cancer Causes Control 26, 65-78 (2015).
41. Gong, T. T., Wu, Q. J., Wang, Y. L. & Ma, X. X. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-Analysis of epidemiologic studies. Int J Cancer 137, 1967-78 (2015).
42. Wu, Q. J., Gong, T. T. & Wang, Y. Z. Dietary fatty acids intake and endometrial cancer risk: A dose-response meta-Analysis of epidemiological studies. Oncotarget 6, 36081-97 (2015).
43. Hou, R., Wu, Q. J., Gong, T. T. & Jiang, L. Dietary fat and fatty acid intake and epithelial ovarian cancer risk: evidence from epidemiological studies. Oncotarget (2015) DOI: 10.18632/oncotarget.5525.
44. Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. (Date of access: 17/November/2015).
45. Wang, Y. Z., Wu, Q. J., Zhu, J. & Wu, L. Fish consumption and risk of myeloma: a meta-Analysis of epidemiological studies. Cancer Causes Control 26, 1307-14 (2015).
46. Greenland, S. Invited commentary: a critical look at some popular meta-Analytic methods. Am J Epidemiol 140, 290-6 (1994).
47. Greenland, S. & O'Rourke, K. On the bias produced by quality scores in meta-Analysis, and a hierarchical view of proposed solutions. Biostatistics 2, 463-71 (2001).
48. Greenland, S. & O' Rourke, K. Meta-Analysis. In: Modern Epidemiology, 3rd edn, (eds Rothman, K. J. et al.) 652-682. (Lippincott Williams & Wilkins, 2008).
49. Hamling, J., Lee, P., Weitkunat, R. & Ambuhl, M. Facilitating meta-Analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 27, 954-70 (2008).
50. DerSimonian, R. & Laird, N. Meta-Analysis in clinical trials. Control Clin Trials 7, 177-88 (1986).
51. Greenland, S. & Longnecker, M. P. Methods for trend estimation from summarized dose-response data, with applications to metaanalysis. Am J Epidemiol 135, 1301-9 (1992).
52. Orsini, N. et al. Meta-Analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175, 66-73 (2012).
53. Bagnardi, V., Zambon, A., Quatto, P. & Corrao, G. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 159, 1077-86 (2004).
54. Royston, P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 19, 1831-47 (2000).
55. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-Analysis. Stat Med 21, 1539-58 (2002).
56. Gong, T. T. et al. Age at menarche and risk of ovarian cancer: a meta-Analysis of epidemiological studies. Int J Cancer 132, 2894-900 (2013).
57. Luan, N. N. et al. Breastfeeding and ovarian cancer risk: a meta-Analysis of epidemiologic studies. Am J Clin Nutr 98, 1020-31 (2013).